chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Blood test, No therapeutic response
Clinical narrative: Information has been received from a nurse concerning a 30 year old female patient who on an unspecified date was vaccinated with MMR II (lot # not reported). Subsequently the patient failed to produce immunity to the mumps and measles, but had immunity to rubella. No treatment was given to the patient. Blood work tests were performed but no results.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Measles
Clinical narrative: Information has been received from a physician assistance concerning a 12 month old male patient who on an unspecified date was vaccinated with a dose of MMR II (lot number not provided). It was reported that within the last month, in January 2011, the patient was given the vaccine and developed what the provider thought was measles. Patient went to the ER for treatment. It was unspecified if lab diagnostic studies were performed. At the time of the report the patient's outcome was unknown. Additional information has been requested.
Age: 24.0
Sex: F
Vaccine: MMR
Symptoms: Accidental exposure, Eye irritation
Clinical narrative: Information has been received from a Practice Administrator concerning a 24 year old female Registered Nurse patient, who on 01-MAR-2011 was preparing to administer a dose of MMR II (lot # unspecified) accidentally splashed some of it in her eye from the vial. Subsequently, the patient experienced burning in her eye. The eye was immediately flushed with water, and the physician on staff, examined the patient's eye. At the time of the report patient's outcome was not reported. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Convulsion
Clinical narrative: Information has been received from a consumer concerning his daughter who on an unspecified date was vaccinated with her first dose of MMR II (Lot # not provided). The consumer stated that his daughter experienced seizures after receiving MMR II. At the time of this report, the patient's outcome was unspecified. It was unknown if the patient sought medical attention. Upon internal review, seizure was considered to be an other important medical event. No further information is available.
Age: 1.01
Sex: M
Vaccine: MMR
Symptoms: Rash, Rash maculo-papular
Clinical narrative: Information has been received from a physician concerning a 12 month old male patient with no pertinent medical history and no drug reactions or allergies who on 21-FEB-2011, was vaccinated SQ with 0.5 ml dose of MMR II (lot# 666250/1070Z). There was no concomitant medication. It was reported that on 26-FEB-2011, the patient developed a rash on his hands and feet. The patient was examined in the office on 01-MAR-2011 and was found to have a diffuse maculo-papular rash. There were no lab diagnostics studies performed. At the time of the report, the patient had not recovered. A standard lot check investigation has been finalized. All in-process quality checks for the lot number 666250/1070Z were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. This is one of several reports received from the same source. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Convulsion, Pyrexia
Clinical narrative: Information has been received from a consumer concerning her "4 1/2 year old" son with peanut allergy and medical history of eczema who in June 2008, was vaccinated with a first dose of MMR II (Dose, route and Lot # not reported). There was no concomitant medication. The consumer stated that on approximately June 2008, "8-10 days after receiving MMR II". Her son developed a fever of 104.5 F and had 2 seizures. TYLENOL and IV fluids were given as a treatment for the events. The patient went to emergency room and was released within 4-5 hours. On an unspecified date the patient recovered. Upon internal review seizures was considered to be an other important medical event. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Lymphadenitis, Lymphadenopathy, Pyrexia, Vomiting
Clinical narrative: Information has been received from a physical therapist concerning her daughter with no pertinent medical history and no drug reactions/allergies who on 06-OCT-2010 was vaccinated with the first dose of MMR II. There was no concomitant medication. On 18-OCT-2010 the patient developed swollen glands on the left side of her neck. The patient was examined by her unspecified physician on that date and was diagnosed with cervical lymphadenopathy or lymphadenitis. She was prescribed AUGMENTIN. On 19-OCT-2010, the patient developed vomiting and a fever of 104F. She was admitted on that date to an unspecified hospital and was treated intravenously with multiple unspecified antibiotics. The patient was discharged from the hospital on 25-OCT-2010. She was currently taking an oral antibiotic at home. The patient was afebrile but the lymphadenopathy was unchanged. At the time of reporting, the patient was recovering from these adverse events. Cervical lymphadenopathy or lymphadenitis, vomiting and a fever of 104F were considered to be other important medical events by the reporter. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a female nurse who since about two years ago, in approximately 2009, had been vaccinated with 3 doses of MMR II (lot numbers not provided) in less than 2 years. The nurse reported that she still did not have protective antibody levels for mumps. It was unspecified if the patient sought medical attention or if any treatment was given. At the time of the report the patient's outcome was unknown. No further information is available.
Age: 1.9
Sex: F
Vaccine: MMR
Symptoms: Febrile convulsion, Tremor
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 23 month old female patient who on 30-JUN-2010 was vaccinated with her first dose of MMR II (lot # unknown). The nurse stated that on 13-JUL-2010, "thirteen days post vaccination" child started shaking and had a seizure. Child was taken to the local emergency room (E.R.), but was not hospitalized. Diagnosis was febrile seizure possible due to the MMR II. On an unspecified date, the patient recovered from febrile seizure. Upon internal review, febrile seizure was considered to be other important medical event. No further information is available.
Age: 36.0
Sex: F
Vaccine: MMR
Symptoms: Condition aggravated, Fatigue, Hypoaesthesia facial
Clinical narrative: Information has been received from a physician concerning a 36 year old female with no drug allergies who "last week", on approximately 21-FEB-2011 was vaccinated subcutaneously with a 1.5 ml dose of MMR II (lot # not provided). There was no concomitant medication. It was reported that the patient experienced left sided facial numbness about 6 hour after the MMR II injection and increased fatigue. No lab diagnostics studies performed. Patient sought unspecified medical attention. At the time of reporting, the patient had not recovered. Follow-up information was received, which stated that the patient's symptoms were fully recovered. No further information is available.
Age: 1.4
Sex: M
Vaccine: MMR
Symptoms: Abasia, Lethargy, Speech disorder, Unresponsive to stimuli
Clinical narrative: Information has been received from a physician concerning a 16 month old male patient with no known drug allergies and no pertinent medical history who on 18-OCT-2007 was vaccinated with a first dose of MMR II (Dose, route and Lot# not reported). There was no concomitant medication. The physician stated that on 18-OCT-2007 the patient became lethargic and nonreactive for 2 weeks after MMR II was administered. The physician also stated that the patient did not speak or walk for 2 weeks. There were no laboratories diagnostics performed. There was no treatment given for the events. The patient sought unspecified medical attention. At the time of the report the patient had recovered. Additional information has been requested.
Age: 1.01
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Convulsion, Rash generalised
Clinical narrative: Information has been received from a Registered Nurse concerning a 12 month old female patient who on 30-AUG-2010 was vaccinated SQ with a 0.5 ml dose of MMR II (Lot# 663511/0443Z) (Expiration date: 25-MAR-2012) and a dose of VARIVAX (Lot#: 667257/0610Z) (Expiration date: 23-APR-2012). The nurse reported that on 31-AUG-2010, the patient experienced body rash and a seizure. Patient went to the emergency room. At the time of the report, the patient was recovering. Upon internal review, seizure was considered to be an other important medical event. Additional information has been requested.
Sex: F
Vaccine: DTAP, MMR
Symptoms: Febrile convulsion
Clinical narrative: Information has been received from a registered nurse concerning a currently 23 year old female who on an unspecified date was vaccinated with a dose of MMR II (lot# not reported). Concomitant therapy included DTaP (unspecified). It was reported that patient had febrile seizures after receiving MMR II and DTaP (unspecified) as a child. At the time of this report, the patient had recovered. Upon internal review, febrile seizure was considered to be an important medical event. No further information is available.
Age: 2.0
Sex: F
Vaccine: MMR, MMR, VARCEL
Symptoms: Injection site anaesthesia, Injection site reaction, Injection site swelling, Joint swelling, Oedema peripheral
Clinical narrative: Information has been received from a licensed practical nurse concerning a 24 month old female patient with no pertinent medical history and no drug reactions or allergies, who on 10-JUN-2010 was vaccinated with a dose of 0.5 milliliter subcutaneous of MMR II (Lot number not provided). Per child's mother, shortly after receiving the vaccine on 10-JUN-2010, ("by the time they got home from the office") the patient experienced numbness and tingling in the arm where injection was given and there was swelling from the site of injection down to the patient's wrist. The mother of the patient reported that all symptoms resolved by 12 am on 11-JUN-2010. The patient sought medical attention, the mother called to the physician office. No treatment was given for the adverse event. No laboratory diagnostics studies were performed. On 11 JUN 2010 at 12 pm, the patient recovered. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: MMR, MMR, VARCEL
Symptoms: Paraesthesia
Clinical narrative: Information has been received from a licensed practical nurse concerning a 24 month old female patient with no pertinent medical history and no drug reactions or allergies, who on 10-JUN-2010 was vaccinated with a dose of 0.5 milliliter subcutaneous of MMR II (Lot number not provided). Per child's mother, shortly after receiving the vaccine on 10-JUN-2010, ("by the time they got home from the office") the patient experienced numbness and tingling in the arm where injection was given and there was swelling from the site of injection down to the patient's wrist. The mother of the patient reported that all symptoms resolved by 12 am on 11-JUN-2010. The patient sought medical attention, the mother called to the physician office. No treatment was given for the adverse event. No laboratory diagnostics studies were performed. On 11 JUN 2010 at 12 pm, the patient recovered. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: MMR, MMR, VARCEL
Symptoms: Condition aggravated, Erythema, Oedema peripheral, Pyrexia
Clinical narrative: Information has been received from a licensed practical nurse concerning a 24 month old female patient with no pertinent medical history and no drug reactions or allergies, who on 10-JUN-2010 was vaccinated with a dose of 0.5 milliliter subcutaneous of MMR II (Lot number not provided). Per child's mother, shortly after receiving the vaccine on 10-JUN-2010, ("by the time they got home from the office") the patient experienced numbness and tingling in the arm where injection was given and there was swelling from the site of injection down to the patient's wrist. The mother of the patient reported that all symptoms resolved by 12 am on 11-JUN-2010. The patient sought medical attention, the mother called to the physician office. No treatment was given for the adverse event. No laboratory diagnostics studies were performed. On 11 JUN 2010 at 12 pm, the patient recovered. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: MMR, MMR, VARCEL
Symptoms: Injection site anaesthesia, Injection site reaction, Injection site swelling, Joint swelling, Oedema peripheral
Clinical narrative: Information has been received from a Licensed practical nurse concerning a 24 month old female patient with a history of high fever following second dose of an unspecified vaccine when she was 16 weeks old, who on 10-JUN-2010, was vaccinated SQ in the right arm with the first dose of MMR II (Lot#: 666295/1776Y) at 11:15 am and the same day, the patient was vaccinated SQ in the left arm with the first dose of VARIVAX (Merck) (Lot# 665969/1447Y) at 11:15am. The physician stated that on 10-JUN-2010, at 11:30 am, the patient had redness after the vaccine was given and the arm gradually became more swollen radiating down to hand and fingers over next several hours until late night time. The patient also had fever within 24 hours from vaccine administration. On 11-JUN-2010 "over following day", the patient had recovered. No relevant diagnostic test was performed. There was no illness at time of vaccination. There were no pre-existing allergies, no birth defects and no medical conditions. The patient did not seek medical attention. No further information is available.
Age: 2.0
Sex: F
Vaccine: MMR, MMR, VARCEL
Symptoms: Paraesthesia
Clinical narrative: Information has been received from a Licensed practical nurse concerning a 24 month old female patient with a history of high fever following second dose of an unspecified vaccine when she was 16 weeks old, who on 10-JUN-2010, was vaccinated SQ in the right arm with the first dose of MMR II (Lot#: 666295/1776Y) at 11:15 am and the same day, the patient was vaccinated SQ in the left arm with the first dose of VARIVAX (Merck) (Lot# 665969/1447Y) at 11:15am. The physician stated that on 10-JUN-2010, at 11:30 am, the patient had redness after the vaccine was given and the arm gradually became more swollen radiating down to hand and fingers over next several hours until late night time. The patient also had fever within 24 hours from vaccine administration. On 11-JUN-2010 "over following day", the patient had recovered. No relevant diagnostic test was performed. There was no illness at time of vaccination. There were no pre-existing allergies, no birth defects and no medical conditions. The patient did not seek medical attention. No further information is available.
Age: 2.0
Sex: F
Vaccine: MMR, MMR, VARCEL
Symptoms: Condition aggravated, Erythema, Oedema peripheral, Pyrexia
Clinical narrative: Information has been received from a Licensed practical nurse concerning a 24 month old female patient with a history of high fever following second dose of an unspecified vaccine when she was 16 weeks old, who on 10-JUN-2010, was vaccinated SQ in the right arm with the first dose of MMR II (Lot#: 666295/1776Y) at 11:15 am and the same day, the patient was vaccinated SQ in the left arm with the first dose of VARIVAX (Merck) (Lot# 665969/1447Y) at 11:15am. The physician stated that on 10-JUN-2010, at 11:30 am, the patient had redness after the vaccine was given and the arm gradually became more swollen radiating down to hand and fingers over next several hours until late night time. The patient also had fever within 24 hours from vaccine administration. On 11-JUN-2010 "over following day", the patient had recovered. No relevant diagnostic test was performed. There was no illness at time of vaccination. There were no pre-existing allergies, no birth defects and no medical conditions. The patient did not seek medical attention. No further information is available.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Febrile convulsion
Clinical narrative: Information has been received from a physician concerning an approximately 12 month old male patient who on an unspecified date was vaccinated with a first dose of MMR II (Lot #, route and injection site not provided). The patient also received other concomitant vaccines (names and manufacturers unspecified). It was reported that the patient experienced a febrile seizure. At the time of this report, the patient had improved. It was unknown if the patient sought medical attention. Upon internal review, febrile seizure was considered to be an other important medical event. No further information is available.
Age: 13.0
Sex: F
Vaccine: MMR
Symptoms: Aspiration bone marrow, Autoimmune thrombocytopenia, Biopsy bone marrow abnormal, Blood count abnormal, Haematology test abnormal
Clinical narrative: Information has been received from a registered nurse consumer concerning her daughter currently 32 years old with unspecified drug reactions/allergies and medical history, who when she was a 13 year old on 18-APR-1991 was vaccinated with a booster of MMR II (route and lot number unspecified). Suspect vaccine included a first dose of "monovalents vaccines" of MMR II (manufacturer unspecified, route and lot number unspecified). It was reported that the patient originally started with "monovalent vaccine" and she did not received MMR II until booster. The registered nurse mother reported that her daughter one week after received a booster menses and after another week developed petichiae. On an unspecified date, the patient went to her physician and the following laboratories were performed: blood count and a bone marrow aspiration (results unspecified) and the patient was diagnosed with thrombocytopenia. The patient was treated with prednisone and globulin, immune therapy (IVIG) until 12-JUN-1997, when she had a splenectomy. The patient was hospitalized (date unspecified). Thorombocytopenia was considered immediately life-threatening, disabling and other important medical event by the consumer. At the time of the report the outcome of the patient was unknown. Follow up information has been received from a Registered Nurse who reported that the patient first seen by the physician on 02-JUL-1991 and the following laboratories were performed: Blood work drawn and showed a platelet count of 20 (NR-150-400) and a bone marrow aspiration that revealed immune thrombocytopenia purpura. The patient was treated with prednisone and immune therapy (IVIG); By 10-JUL-1991, the patient's platelets were back up to 220 patient's splenectomy was performed on 12-JUN-1997 (not in 1987). In 2002, the patient visited the physician and a platelet count at that time was 507 and considered recovered. According with the nurse, the physician felt that event was not related to the MMR II vaccine. The health care professional contacted during telephone follow-up could not supply the following information: lot number and hospital name. No further information is available.
Age: 13.0
Sex: F
Vaccine: MMR
Symptoms: Immunoglobulin therapy, Menorrhagia, Petechiae, Platelet count decreased, Platelet count increased
Clinical narrative: Information has been received from a registered nurse consumer concerning her daughter currently 32 years old with unspecified drug reactions/allergies and medical history, who when she was a 13 year old on 18-APR-1991 was vaccinated with a booster of MMR II (route and lot number unspecified). Suspect vaccine included a first dose of "monovalents vaccines" of MMR II (manufacturer unspecified, route and lot number unspecified). It was reported that the patient originally started with "monovalent vaccine" and she did not received MMR II until booster. The registered nurse mother reported that her daughter one week after received a booster menses and after another week developed petichiae. On an unspecified date, the patient went to her physician and the following laboratories were performed: blood count and a bone marrow aspiration (results unspecified) and the patient was diagnosed with thrombocytopenia. The patient was treated with prednisone and globulin, immune therapy (IVIG) until 12-JUN-1997, when she had a splenectomy. The patient was hospitalized (date unspecified). Thorombocytopenia was considered immediately life-threatening, disabling and other important medical event by the consumer. At the time of the report the outcome of the patient was unknown. Follow up information has been received from a Registered Nurse who reported that the patient first seen by the physician on 02-JUL-1991 and the following laboratories were performed: Blood work drawn and showed a platelet count of 20 (NR-150-400) and a bone marrow aspiration that revealed immune thrombocytopenia purpura. The patient was treated with prednisone and immune therapy (IVIG); By 10-JUL-1991, the patient's platelets were back up to 220 patient's splenectomy was performed on 12-JUN-1997 (not in 1987). In 2002, the patient visited the physician and a platelet count at that time was 507 and considered recovered. According with the nurse, the physician felt that event was not related to the MMR II vaccine. The health care professional contacted during telephone follow-up could not supply the following information: lot number and hospital name. No further information is available.
Age: 13.0
Sex: F
Vaccine: MMR
Symptoms: Splenectomy, Thrombocytopenic purpura
Clinical narrative: Information has been received from a registered nurse consumer concerning her daughter currently 32 years old with unspecified drug reactions/allergies and medical history, who when she was a 13 year old on 18-APR-1991 was vaccinated with a booster of MMR II (route and lot number unspecified). Suspect vaccine included a first dose of "monovalents vaccines" of MMR II (manufacturer unspecified, route and lot number unspecified). It was reported that the patient originally started with "monovalent vaccine" and she did not received MMR II until booster. The registered nurse mother reported that her daughter one week after received a booster menses and after another week developed petichiae. On an unspecified date, the patient went to her physician and the following laboratories were performed: blood count and a bone marrow aspiration (results unspecified) and the patient was diagnosed with thrombocytopenia. The patient was treated with prednisone and globulin, immune therapy (IVIG) until 12-JUN-1997, when she had a splenectomy. The patient was hospitalized (date unspecified). Thorombocytopenia was considered immediately life-threatening, disabling and other important medical event by the consumer. At the time of the report the outcome of the patient was unknown. Follow up information has been received from a Registered Nurse who reported that the patient first seen by the physician on 02-JUL-1991 and the following laboratories were performed: Blood work drawn and showed a platelet count of 20 (NR-150-400) and a bone marrow aspiration that revealed immune thrombocytopenia purpura. The patient was treated with prednisone and immune therapy (IVIG); By 10-JUL-1991, the patient's platelets were back up to 220 patient's splenectomy was performed on 12-JUN-1997 (not in 1987). In 2002, the patient visited the physician and a platelet count at that time was 507 and considered recovered. According with the nurse, the physician felt that event was not related to the MMR II vaccine. The health care professional contacted during telephone follow-up could not supply the following information: lot number and hospital name. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a the patient's mother concerning her son (age unspecified) who in approximately 2009 ("about a year and a half") was vaccinated with MMR II, 0.5ml, two doses administered, subcutaneously. (Lot number not reported). The patient's mother said stated that her son broke out in a rash after being administered MMR II 0.5ml. It was reported that she was seeking one rubella vaccination because she did not want her son to received a third dose of the medication. She said her son received two doses. The patient sought unspecified medical attention. At the time of the report, patient's outcome was unknown. No further information is available.
Age: 40.0
Sex: M
Vaccine: MMR
Symptoms: Blood immunoglobulin G, Measles antibody negative
Clinical narrative: Information has been received from a Registered Nurse (R.N.) concerning a 40 year old male patient with immunosuppression and ulcerative colitis who was not sure if received the MMR II in childhood (on an unspecified date) since he could not provide any record. It was also noted that the patient informed the nurse that he was in military and was vaccinated for "everything" but could not showed the documentations either. On 10-MAR-2011 the patient was vaccinated with a dose of MMR II (lot no. 667741/0811Z, exp. 10-JUN-2012) dose and route not reported. Concomitant therapies included prednisone, balzalaside and mercaptopurine. The nurse reported that the patient showed "negative titer for measles" when tested (date unspecified). The nurse stated that on 10-MAR-2011 when the vaccine was administered the patient "might be immunosupressed" and it was found out that patient suffered from ulcerative colitis and was taking prednisone 30 mg, balsalazide and mercaptopurine. At the time of reporting, the patient was on "a 3 week burst therapy and was weaning off". The patient sought unspecified medical attention. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Injection site pain
Clinical narrative: Information has been received from a registered pharmacist concerning a patient with no drug reactions or allergies who on 17-MAR-2011 was vaccinated with a dose of 0.5 milliliters of MMR II intramuscularly (lot number not provided). The patient experienced pain at injection site. Laboratory diagnostics studies were not performed. No treatment for the adverse event was given. The patient did not seek medical attention. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Injection site pain
Clinical narrative: Information has been received from a 30 year old female pharmacist with no pertinent medical history and no known drug reactions/allergies, who on approximately 01-OCT-2010, in early October 2010, was vaccinated IM with a 0.5ml dose of MMR II (Lot number not provided). There was no concomitant medication. The pharmacist reported that she was vaccinated and she experienced pain at the injection site for the whole day. The patient did not seek medical attention. No treatment was provided. No lab diagnostic studies were performed. At the time of the report the patient had recovered (date unspecified). Additional information has been requested.
Age: 39.0
Sex: F
Vaccine: MMR
Symptoms: Accidental exposure, Eye irritation
Clinical narrative: Information has been received from a healthcare worker concerning a 39 year old female medical assistant with no medical history and no drug allergies who on 21-MAR-2011 splashed in the eye with MMR II. The medical assistant was reporting eye irritations, and the medical assistant flushed eye with water. No lab diagnostics studies performed. It was unspecified whether the medical assistant sought medical attention, although it happened in physician's office. At the time of the report, the medical assistant was not recovered. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a registered nurse (R.N) concerning an adult female with sulfa drug reactions who on 18-MAR-2011, was vaccinated with a dose (it was unknown if this was the first or second dose) of MMR II (Lot # not reported). About on 20-MAR-2011 "about 2 days later", the patient developed a rash. There was not description of the rash available. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Age: 1.25
Sex: F
Vaccine: DTAPIPVHIB, VARCEL
Symptoms: Injection site erythema, Injection site papule, Injection site rash
Clinical narrative: 10 days after receiving Varivax vaccine in right thigh, parent noticed redness and red bumps on injection site on right thigh. Physician noted round area of redness with 3-4 papules inside the red area.  No treatment was required.
Age: 17.0
Sex: M
Vaccine: HPV4, IPV
Symptoms: Burning sensation, Rash
Clinical narrative: RASH OVER ARMPIT BACK AND RIGHT SHOULDER, BURNING OVER ARMPIT
Age: 15.0
Sex: F
Vaccine: FLUX, HEP, IPV, MMR, TDAP
Symptoms: Pruritus, Urticaria
Clinical narrative: 11:05am Aunt escorted her in to HS clinic after receiving 5 vaccs (HepB, IPV, influenza, MMR, & Tdap).  Hives on face, itching. No other symptoms. T 97.5 P92 reg, BP 118/80. Called Clinic to inform.  Recommend to Aunt to call her HCP (on catch-up schedule: ck if she should go for next round of shots in July). Aunt plans to give her Benadryl & Tylenol & will monitor. Instructed to take her to urgent care if develops any probs with breathing, swelling, etc.  Aunt verbalizes understanding.  Student left ambulatory with aunt. Next day 5/18/11 student returned to school, no other probs.
Age: 54.0
Sex: F
Vaccine: DTAP, TD
Symptoms: Asthenia, Convulsion, Dizziness, Eye disorder, Fatigue
Clinical narrative: tired, weakness, shaky, dizzy, seizures, body aches, eye problems
Age: 54.0
Sex: F
Vaccine: DTAP, TD
Symptoms: Pain, Tremor
Clinical narrative: tired, weakness, shaky, dizzy, seizures, body aches, eye problems
Age: 4.0
Sex: M
Vaccine: DTAP, MMR
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Swelling and erythema at left entire arm 5/19/11.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Dizziness, Pyrexia, Streptococcus test negative
Clinical narrative: High fever 103.7 oral and dizziness started morning after injections.
Age: 1.03
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Erythema, Pyrexia, Rash erythematous, Rash maculo-papular
Clinical narrative: Low grade fever, diffuse erythematous maculopapular rash, very slight conjuctival erythema.  Duration approx 5 days.
Age: 48.0
Sex: M
Vaccine: HEPA
Symptoms: Rash
Clinical narrative: 6 X 2 inch strip of rash just under both breasts around 12 pm.  Shower followed by application of aloe eliminated it within an hour.  Next day about 11 am, there was a light Rash at bottom of bicep area on right hands.  Again shower then aloe eliminated it within 2 hours.
Age: 30.0
Sex: M
Vaccine: ANTH, MNQ
Symptoms: Flushing, Nausea
Clinical narrative: Patient come to clinic for Anthrax #1 and MGC.  Patient was administered Anthrax #1 in the right deltoid and MGC in the left deltoid.  Patient tolerated both immunizations well, but when he sat down he became flush in the face and expressed nausea. Patient was immediately wheelchaired to a patient bed and was administed some water to drink with his legs elevated.  Evolution lasted approx. 12 minutes total.
Age: 51.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Feeling hot, Pruritus
Clinical narrative: redness, warmth, itching
Age: 1.09
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Erythema, Rash, Varicella
Clinical narrative: Patient woke up in the morning with red bumps/rings on face, back, belly, bilateral arms, bilateral legs and patient has a chick pox on his buttocks.
Age: 57.0
Sex: M
Vaccine: HEPA
Symptoms: Epistaxis
Clinical narrative: Nose started slowly bleeding from left nostril.  Patient lay down and went to sleep and it found that it stopped.  Did not plug nose.
Age: 65.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Chills, Erythema, Pain in extremity, Pyrexia
Clinical narrative: Fever over 101 degrees F and chills and painful arm every 4 hrs after effects of Tylenol or ibuprofen wore off approximately 48 hrs.  Painful and red arm persisted 7 days.
Age: 74.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Injection site erythema, Injection site pain, Injection site warmth, Tremor
Clinical narrative: Rec'd call from pts daughter from home to report that pt started with chills/tremors & pain-redness-warmth to Lt arm injection site @ approx 130pm. Instructed to report to Hospital ER for prompt MD care.
Age: 0.25
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Food allergy, Gaze palsy, Headache, Loss of consciousness, Neck pain
Clinical narrative: Baby did not appear to notice vaccine administration. Within approximately 2 minutes his eyes rolled back and he appeared to "pass out". We took this for sleeping, although it seemed very odd at the time. Approximately 30-45 minutes later baby awoke with an inconsolable, frightening high-pitched scream which went on for 30 minutes. Baby appeared to be experience horrible head and neck pain. Pediatrician was immediately called and advised to give Tylenol. Baby slept after 45 minutes until the following day, waking only for occasional nursing. Pediatrician refused to document any unusual reaction. Likely unrelated, but three months later child diagnosed with multiple very severe food allergies and otherwise normal development.
Age: 0.25
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Screaming
Clinical narrative: Baby did not appear to notice vaccine administration. Within approximately 2 minutes his eyes rolled back and he appeared to "pass out". We took this for sleeping, although it seemed very odd at the time. Approximately 30-45 minutes later baby awoke with an inconsolable, frightening high-pitched scream which went on for 30 minutes. Baby appeared to be experience horrible head and neck pain. Pediatrician was immediately called and advised to give Tylenol. Baby slept after 45 minutes until the following day, waking only for occasional nursing. Pediatrician refused to document any unusual reaction. Likely unrelated, but three months later child diagnosed with multiple very severe food allergies and otherwise normal development.
Age: 13.0
Sex: M
Vaccine: MNQ
Symptoms: Loss of consciousness, Musculoskeletal stiffness
Clinical narrative: BRIEF MOMENT LOST OF CONSCIOUSNESS, BRIEF TONICITY ON THE ARMS AS SHE LOC
Age: 0.21
Sex: M
Vaccine: HIBV
Symptoms: Crying, Irritability, Pyrexia
Clinical narrative: Fever of 100 to 100.3 degrees from 8p til the next day, 8a. Fussy and crying all night.
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Induration, Pruritus, Swelling
Clinical narrative: Swelling. Red. Itch. Hard. TDAP given at Public Health Dept.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Swelling and tenderness at Rt quadriceps with some swelling of the knees.
Age: 24.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Induration, Mass, Pain, Skin warm
Clinical narrative: 1 1/2 x 1 1/4" red, swollen, hard, painful hot to touch area, lump lasted 8 days.
Age: 24.0
Sex: F
Vaccine: TDAP
Symptoms: Swelling
Clinical narrative: 1 1/2 x 1 1/4" red, swollen, hard, painful hot to touch area, lump lasted 8 days.
Age: 13.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Oedema peripheral, Pyrexia, Skin warm
Clinical narrative: Fevers & localized right arm warmth, and arm swelling.
Age: 39.0
Sex: F
Vaccine: TDAP
Symptoms: Arthralgia, Pruritus, Rash
Clinical narrative: Rec. IM Tdap 5-23-11. Noticed rash over abd, arm 5-24-11 PM. Spread to back & feels "itchy" in AM 5-25-11. Seen in Employee Health. Given BENADRYL mg. Instr. to take 50mg q6 hrs for itching & rash. F/U appt. made for 5/26/11. Developed joint pain x 36 hours started on 5-28-11.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, HEPA, MMRV
Symptoms: Erythema, Rash generalised, Throat irritation, Urticaria
Clinical narrative: Parent called to our facility less than 1 hour after leaving the office. Patient complained of scratchy throat. 20 min afterwards the patient was found to have a generalized rash - (hives) erythematous wheals. Tx BENADRYL.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Injection site nodule, Oedema peripheral, Pain
Clinical narrative: 5/8/11 swelling & redness of entire arm, a knot at site of vaccine, all over body aches. Urgent care treated with 5 days of Antibiotics, Prednisone.
Age: 4.0
Sex: M
Vaccine: DTAP, MMRV
Symptoms: Erythema, Injection site swelling, Oedema peripheral, Urticaria
Clinical narrative: Rt upper arm all swollen to below the elbow red & hot.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Allergy test positive, Food allergy, Measles antibody negative, Nasal congestion, Pruritus
Clinical narrative: Information has been received from a consumer concerning her approximately 12 month old son with a history of intussusception and appendix removed and no drug reactions or allergies who on approximately 11-SEP-2005 was vaccinated with a dose of MMR II (Lot #, expire date and route not reported). There was no concomitant medication. Consumer stated that when her son was around 12 months old after receiving MMR II in approximately 11-SEP-2005, her son experienced rash and itching. Consumer mentioned she noticed a lot more reactions to many types of food with rash and itching after receiving MMR II. Consumer added that on an unspecified date, an allergy test was ordered by physician and her son was found to be allergic to egg white. Consumer also reported that her son's nose was always stuffy. On an unspecified date, antibody levels for measles were measured and showed low antibody levels and physician ordered a booster shot with receiving MMR II. Consumer said creams were given as treatment. At the time of the report, the outcome of the patient was unknown. Follow up information received from the physician on 27-JAN-2011, she stated that she did not have any contact from the patient's parents for 10 days after immunizing the patient. The reason they contacted her because the whole family had strep on an unspecified date, outcome was not reported. Follow up information was received from the physician, who stated that the patient never had intussusception, he had is appendix removed laparoscopically, and he had the appendix removed before MMR II. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a consumer concerning her approximately 12 month old son with a history of intussusception and appendix removed and no drug reactions or allergies who on approximately 11-SEP-2005 was vaccinated with a dose of MMR II (Lot #, expire date and route not reported). There was no concomitant medication. Consumer stated that when her son was around 12 months old after receiving MMR II in approximately 11-SEP-2005, her son experienced rash and itching. Consumer mentioned she noticed a lot more reactions to many types of food with rash and itching after receiving MMR II. Consumer added that on an unspecified date, an allergy test was ordered by physician and her son was found to be allergic to egg white. Consumer also reported that her son's nose was always stuffy. On an unspecified date, antibody levels for measles were measured and showed low antibody levels and physician ordered a booster shot with receiving MMR II. Consumer said creams were given as treatment. At the time of the report, the outcome of the patient was unknown. Follow up information received from the physician on 27-JAN-2011, she stated that she did not have any contact from the patient's parents for 10 days after immunizing the patient. The reason they contacted her because the whole family had strep on an unspecified date, outcome was not reported. Follow up information was received from the physician, who stated that the patient never had intussusception, he had is appendix removed laparoscopically, and he had the appendix removed before MMR II. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: DTAPIPVHIB, FLU3, MMR
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a 4 year old male with no pertinent medical history or drug reactions/allergies who on 03-JAN-2011 was vaccinated subcutaneously with a dose of MMR II (lot # 666512/1709Y, expiration date unknown). Concomitant therapy included FLUZONE and PENTACEL. On 05-JAN-2011 the patient returned to the office with a 4 inch by 4 inch rash on his left thigh, the child was given BENADRYL and was told to use ice on the area. The condition was resolving at the time of reporting. No laboratory diagnostics study was performed. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Erythema multiforme
Clinical narrative: Information has been received from a physician who found a case of a kid who was vaccinated with MMR II and experienced erythema multiforme-like eruptions when the patient got the vaccine followed by amoxicillin. At the time of the report, the patient's outcome was unknown. This is one of three reports received from the same source. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a physician concerning a 3 year old female patient who on 17-MAR-2002 was vaccinated with a dose of MMR II (Lot #, expire date and route not reported). Physician stated that on an unspecified date, mumps titers were measured and were negative. At the time of the report, the outcome of the patient was unknown. The patient had a history of shingles and negative varicella antibody titer on therapy with VARIVAX (Merck) (WAES # 1008USA01283). Additional information has been requested.
Age: 38.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a nurse practitioner concerning a 38 year old female patient with migraines and no allergies who on unspecified date "as young child" was vaccinated with a w/diluent s-dose of MMR II (Lot# not reported). There was no concomitant medication. The nurse reported that on 14-JAN-2011 a titer was performed, that was negative at 0.46 measles. At the time of the report the patient had not recovered. The patient sought unspecified medical attention. Additional information has been requested.
Age: 1.36
Sex: M
Vaccine: FLU3, MMR
Symptoms: Rash generalised, Rash macular
Clinical narrative: Information has been received from a Certified Medical Assistant (C.M.A.) concerning a 16 month old male with no pertinent medical history and no known drug reactions/allergies who on 04-JAN-2011 was vaccinated with the first 0.5 ml dose of MMR II (lot#665427/0667Z) in left thigh. Concomitant therapy on the same day included influenza virus vaccine (unspecified) (manufacturer unknown). On 14-JAN-2011 the patient was brought into the office and had a rash from head to toe. The patient was treated with calamine lotion. There was no lab diagnostics studies performed. At the time of the report, the outcome was unknown. Follow up information has been received from the reporting medical assistant concerning the male who at 13:00 on 04-JAN-2011 received the above vaccine. At pm of 14-JAN-2011, the patient developed diffuse red macular rash all over the body and on the head. At the time of the report, the patient had recovered from his adverse event. The patient did not seek require emergency room/doctor visit. Additional information is not expected.
Age: 35.0
Sex: M
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test, No therapeutic response, Rubella antibody test
Clinical narrative: Information has been received from nurse practitioner concerning a 35 year old male who receive his first dose of MMR II as a child, the exact date and exact product that the patient received as a child were unspecified. In 2009 the patient had a negative titer for rubeola (measles). In July 2009 (also reported as September 2009) the patient was vaccinated with second dose of MMR II (lot # not reported). On 19-JAN-2011 the patient again had a negative titer for rubeola (measles). No adverse event were noted other than the failure to seroconvert to rubeola (measles). Immunity to the other components of the MMR II was not in question. Blood work for immunity to measles, mumps and rubella was performed. The patient sought a medical attention to the office. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Information has been received from a consumer concerning her son who on unspecified date was vaccinated with a dose of MMR II (Dose, route and lot# not reported). The consumer stated that her son on unspecified date had experienced high fever after receiving MMR II. At the time of the report the patient's outcome was unknown. It was unspecified if the patient sought medical attention. Additional information is not expected.
Age: 30.0
Sex: U
Vaccine: MMR
Symptoms: Mumps, Rubulavirus test positive
Clinical narrative: Information has been received from a licensed visiting nurse concerning a patient in his/her 30's who at some point in his/her childhood was vaccinated with a dose of MMR II (lot number not reported). It was reported that the patient was a confirmed case of mumps in a local correctional facility. A laboratory test confirmed that the patient had mumps. The patient was not hospitalized. At the time of the report, the patient's outcome was unknown. It was unknown if the patient sought medical attention. All telephone call attempts to obtain follow-up information have been unsuccessful. This is one of several reports received from the same source. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Adverse reaction
Clinical narrative: Information has been received from a consumer concerning her daughter who on an unspecified date was vaccinated with a dose of MMR II (therapy route and lot # not provided). On an unspecified date, the patient had a reaction to the MMR II. At the time of reporting, the patient's status was not provided. No further information is available.
Age: 60.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Diarrhoea, Lymphadenopathy, Nausea, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 60 year old female patient with cancer, on chemotherapy, allergy to DILAUDID and penicillin, and a history of thymectomy, "9 months ago", who on 03-FEB-2011 was vaccinated with a first dose of MMR II. There was no concomitant medication. The nurse reported that the patient developed nausea, vomiting, diarrhea a rash on her face and neck with joint pain and swollen lymph nodes. The nausea diarrhea and vomiting occurred on 12-FEB-2011 and 13-FEB-2011 and then resolved. The patient then developed a rash on her face and neck with joint pain and swollen lymph nodes on 14-FEB-2011. The rash was described as measles like rash. The rash started on the face and neck and proceeded down her body and now was a generalized rash. The patient had no previous vaccination history with MMR II, but was determined to have immunity to mumps and measles, but no immunity to German measles with an unspecified screening test. The patient sought unspecified medical attention. It was reported that on 18-FEB-2011 the patient was treated with ALLEGRA and MOTRIN. At the time of the report, the patient had not recovered from rash on her face and neck with joint pain, swollen lymph nodes and generalized rash. Additional information has been requested.